Skip to main content
OpenTrials

Clinical trial condition

Hereditary Angioedema

Explore clinical trials studying Hereditary Angioedema. Study availability and eligibility vary by location and protocol.

78 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Angioedema trial results

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

NCT00462709

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Consultants, Inc Hoover, Alabama, United States
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • Allergy and Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
View all 48 locations
View Trial Details
Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

NCT00438815

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allergy and Immunology Associates Scottsdale, Arizona, United States
  • Allergy and Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • UCLA-David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 30 locations
View Trial Details
Completed

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

NCT00432510

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • University of California, San Diego San Diego, California, United States
  • Allergy and Asthma Clinical Research, Inc. Walnut Creek, California, United States
  • Family Allergy and Asthma Center Atlanta, Georgia, United States
  • Institute for Asthma and Allergy Wheaton, Maryland, United States
View Trial Details
Completed

A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

NCT02247739

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • University of South Florida Asthma, Allergy and Immunology Clinical Research Unit Tampa, Florida, United States
  • University of South Florida, Asthma, Allergy & Immunology Clinical Research Unit Tampa, Florida, United States
  • Washington University Division of Allergy and Immunology St Louis, Missouri, United States
  • Baker Allergy, Asthma and Dermatology Research Center Lake Oswego, Oregon, United States
View Trial Details

Related conditions